USPSTF: Evidence Lacking to Recommend Skin Cancer Screens

Share this content:
USPSTF: Evidence Lacking to Recommend Skin Cancer Screens
USPSTF: Evidence Lacking to Recommend Skin Cancer Screens

TUESDAY, July 26, 2016 (HealthDay News) -- There is insufficient evidence to recommend regular full-body exams for skin cancer as a means of preventing deaths from these cancers, according to a new review and recommendation statement published in the July 26 issue of the Journal of the American Medical Association.

The new report doesn't change the Task Force's prior statement on skin cancer screening issued in 2009. This latest update is "an explicit call for more evidence," David Grossman, M.D., M.P.H., vice-chairperson of the U.S. Preventive Services Task Force, told HealthDay, adding that very little new research has surfaced on either the benefits or the harms of screening for skin cancer during the past seven years.

The largest recent study involved more than 360,000 people in northern Germany who received regular skin screening as well as education on sun protection, Grossman said. That study showed a nearly 50 percent decline in mortality rates from melanoma in men, and improved melanoma mortality rates compared with other nearby regions. "It's unclear whether the drop they saw in mortality is related to the screening or to improved behavioral response, with people using skin protection," Grossman said. In addition, "that rate wasn't sustained over time," he said. "If we saw a number of studies like this and they all were consistent and sustained, we would consider such evidence."

In an accompanying editorial, dermatologist Martin Weinstock, M.D., Ph.D., of Brown University's Warren Alpert Medical School in Providence, R.I., argued that "insufficient evidence of benefit" doesn't mean the same thing as "evidence of no benefit." The largest benefit of regular skin exams would be catching a melanoma before it became invasive. "The worst risk would be unnecessary biopsies that could lead to scarring of a person's skin and greater health care costs," he told HealthDay.

Recommendation Statement
Evidence Report
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

900 Steps Tied to Functional Decline in Hospitalized Seniors

<900 Steps Tied to Functional Decline in Hospitalized ...

Walking <900 steps/day linked to hospitalization-associated functional decline

Thromboprophylaxis Not Effective After Knee Arthroplasty, Casting

Thromboprophylaxis Not Effective After Knee Arthroplasty, Casting

Does not prevent venous thromboembolism after knee arthroplasty, casting of lower leg

ASH: Lower Rate of Sickle Cell Pain Crises With Crizanlizumab

ASH: Lower Rate of Sickle Cell Pain Crises ...

Lower rate of crises per year; longer median time to first, second crises with high-dose therapy

is free, fast, and customized just for you!

Already a member?

Sign In Now »